SCHEMBL1729795

SCHEMBL1729795

NC(=O)CN(CC1CCN(c2ccc(C(F)(F)F)cn2)CC1)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.60
KDM4E B2RXH2 2/20 0.60
ABL1 P00519 1/20 0.60
CHRM4 P08173 1/20 0.49
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
HPGD P15428 1/20 0.47
CHRM2 P08172 1/20 0.47
CHRM1 P11229 1/20 0.47
HSD11B1 P28845 1/20 0.46
L3MBTL1 Q9Y468 4/20 0.46
CYP3A4 P08684 1/20 0.46
DPP4 P27487 3/20 0.46
PKM P14618 1/20 0.46
MAPT P10636 3/20 0.45
HTT P42858 1/20 0.45
JAK2 O60674 1/20 0.45
JAK3 P52333 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1729688 0.91 LMNA (0.59) LMNAKDM4EABL1CHRM4MEN1
SCHEMBL1730318 0.84 HRH3 (0.43) LMNAKDM4EABL1KMT2ASMN1; SMN2
SCHEMBL1727687 0.84 PDE10A (0.43) LMNAKDM4EABL1CHRM4KMT2A
SCHEMBL1728906 0.84 DEGS1 (0.48) LMNAKDM4EABL1SMN1; SMN2MAPT
SCHEMBL1727662 0.82 HTR1A (0.43) LMNAKDM4EABL1CHRM4
SCHEMBL30286305 0.82 KDM4E (0.71) LMNAKDM4EABL1CHRM4MEN1
SCHEMBL1729359 0.82 KDM1A (0.45) LMNAALDH1A1KMT2ASMN1; SMN2MAPT
SCHEMBL1729679 0.81 CHRM4 (0.48) CHRM4CHRM2CHRM1DPP4JAK2
SCHEMBL3783822 0.81 KDM4E (0.57) LMNAKDM4EABL1CHRM4MEN1
SCHEMBL30286061 0.79 KDM4E (0.65) LMNAKDM4EABL1CHRM4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633735-B1 DERIVATIVES OF PIPERIDINYL- AND PIPERAZINYL-ALKYL CARBAMATES, PREPARATION METHODS THEREOF AND APPLICATION OF SAME IN THERAPEUTICS SANOFI SA (FR) 2011-11-30 EP claimed